Company Name: Ablynx NV

Ablynx NV is a biopharmaceutical company. The company is engaged in the development of treatments for a variety of conditions in areas that include haematology, immuno-oncology, inflammation, oncology and respiratory disease using its proprietary Nanobody platform.

Ticker Symbol: ABLX (NASDAQ)

Company Website: http://www.ablynx.com

Social Media:

Ablynx Linkedin

Ablynx Twitter

Ablynx Facebook

Ablynx YouTube

Headquarters: Ghent/Zwijnaarde, Belgium